Scientist/Sr. Scientist, Disease Biology – Translational Research
HiFiBiO (HK) Limited
- Company Industries:Medical / Pharmaceutical
Job Information
- Post Date:2020-03-21
- Career Level:Middle
- Location:Not Specified
- Yr(s) of Exp:2 years
- Qualification:Postgraduate
- Salary:Salary negotiable
- Employment Type:Full Time
- Job Function:Life Science
Job Description
Key Responsibilities:
The selected candidate will be part of the Disease Biology team and contribute to the progression of HiFiBiO pipeline of immunomodulatory therapeutic antibodies. The position responsibilities include:
• Designing and performing translational studies using cell lines or primary human cells
• Performing assay development and assay validation when needed
• Working both independently and with the team to analyze data generated from experiments, drawing appropriate conclusions and deciding upon next steps
• Collaborating effectively with other functional groups both intra and inter sites
• Collaborating with local universities and research centers
• Contributing to patent filings and publications and present research finding to various audiences including senior management.
Requirements:
• PhD in Immunology, Oncology, Biology or related fields with 2+ years of post-graduate experience-preferably in industrial setting or Master in related fields with 5+ years of industrial experience
• Working-experience in drug discovery or translational studies or biomarker discovery preferred
• Strong understanding in immunology, oncology and immunological assays are pluses
• Strong experience with cell biology techniques is essential; working experience with immunology assays and flow cytometry
• Drive to work on a fast-paced and highly collaborative team
• Demonstrated excellence in standard laboratory technical skills and solid scientific track record
• Strong communication skills are required
• Must be self-driven, and motivated
• Responsibilities commensurate with experience level
Company Info
Contact
-
Please login
Position | Company | Location | Update |
---|